TABLE 2.
Susceptibility of norM-harboring E. coli TG1ΔacrAB to different compounds
| Compounda | MIC (μg/ml)b
|
|
|---|---|---|
| TG1ΔacrAB | TG1ΔacrAB/pVC102 | |
| NOR | 0.016 | 1 |
| CIP | 0.004 | 0.125 |
| EtBr | 2 | 32 |
| CCCP | 32 | 32 |
| NOR plus CCCP | 0.016 | 0.016 |
| CIP plus CCCP | 0.004 | 0.004 |
| EtBr plus CCCP | 1 | 1 |
| SPX | 0.007 | 0.007 |
| KAN | 1 | 4 |
| TET | 0.25 | 0.25 |
| CHL | 1 | 1 |
| Streptomycin | 2 | 4 |
| Erythromycin | 0.5 | 1 |
| Doxorubicin | 8 | 16 |
| Novobiocin | 2 | 2 |
| Rhodamine 6G | 16 | 16 |
| Acriflavin | 2 | 2 |
a
NOR, norfloxacin; CIP, ciprofloxacin; EtBr, ethidium bromide; SPX, sparfloxacin; KAN, kanamycin; TET, tetracycline; CHL, chloramphenicol.
b
All experiments were carried out thrice with the same results.